Transient ischaemic attack, vascular risk factors and cognitive impairment: A case-controlled study

Age and Ageing

Volumn 40, Issue 5, 2011, Pages 641-644

  Guyomard, Veronique ^a   Metcalf, Anthony K ^a   Naguib, Magdi F ^a   Fulcher, Robert A ^a   Potter, John F ^a,b   Myint, Phyo K ^a,b  

^a Stroke Research Group   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ATTENTION; CALCULATION; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CAUCASIAN; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; HYPERTENSION; LANGUAGE; LETTER; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL CONCENTRATION; ORIENTATION; PRIORITY JOURNAL; RISK FACTOR; THINKING; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 80051745499     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afr079     Document Type: Letter

References (26)

1. Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology 2005; 24: 42-50.
2. Saxby BK, Harrington F, McKeith IG, Wesnes K, Ford GA. Effects of hypertension on attention, memory, and executive function in older adults. Health Psychol 2003; 22: 587-91.
3. Prencipe M, Santini M, Casini AR, Pezzella FR, Scaldaferri N, Culasso F. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors. J Neurol 2003; 250: 907-12.
4. Triantafyllidi H, Arvaniti C, Lekakis J et al. Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension. Am J Hypertens 2009; 22: 525-30.
5. Wessels AM, Rombouts SA, Remijnse PL et al. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 2007; 50: 1763-9.
6. Laukka EJ, Jones S, Fratiglioni L, Backman L. Cognitive functioning in preclinical vascular dementia: a 6-year follow-up. Stroke 2004; 35: 1805-9.
7. Folstein MF, Folstein SE, McHugh SE. Minor-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
8. Nasreddine ZS, Phillips NA, Bedirian V. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-9.
9. Kalbe E, Kessler J, Calabrese P et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19: 136-43.
10. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham Heart Study. Int J Obes Relat Disord 2003; 27: 260-8.
11. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004; 26: 1044-80.
12. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008; 7: 246-55.
13. Albers GW, Caplan LR, Easton JD et al. TIA Working Group. Transient ischemic attack-proposal for a new definition. N Engl J Med 2002; 347: 1713-6.
14. Williams B, Poulter NR, Brown MJ et al. The BHS Guidelines Working Party Guidelines for Management of Hypertension: Report of the Fourth Working Party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-85.
15. Hoops S, Nazem S, Siderowf AD et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73: 1738-45.
16. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by mini-mental state examination versus the montreal cognitive assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010; 41: 1290-3.
17. Smith T, Gildeh N, Holmes C. The montreal cognitive assessment: validity and utility in a memory clinic setting. Can J Psychiatry 2007; 52: 329-32.
18. Birns J, Morris R, Donaldson N, Kalra L. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006; 24: 1907-14.
19. Sachdev PS, Brodaty H, Valenzuela M et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 2004; 62: 912-9.
20. Rao R, Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease: a comparison with healthy community residents. Stroke 1999; 30: 2167-73.
21. Bravo G, Hébert R. Reliability of the modified Minor-Mental State Examination in the context of a two-phase community prevalence study. Neuroepidemiology 1997; 16: 141-8.
22. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993; 50: 162-6.
23. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database System Rev 2006: CD004034.
24. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009; 73: 120-5.
25. Feldman H, Jacova C, Robillard A et al. Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ 2008; 178: 825-36.
26. Pendlebury ST, Cuthbertson FC, Welch SJV, Rothwell PM. Substantial underestimation of cognitive impairment by MMSE in patients with TIA and stroke: a population based study using the MOCA. Cerebrovas Diseases 2009; 27(Suppl. 6): 55.